puromycin aminonucleoside and Diabetes Mellitus, Type 1

puromycin aminonucleoside has been researched along with Diabetes Mellitus, Type 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buckley, AF; Fields, TA; Gomez, JA; Jirka, G; Rosenberg, PB; Spurney, RF; Wang, L; Winn, MP	1

Other Studies

1 other study(ies) available for puromycin aminonucleoside and Diabetes Mellitus, Type 1

Article	Year
Gq signaling causes glomerular injury by activating TRPC6. The Journal of clinical investigation, 2015, Volume: 125, Issue:5 Topics: Albuminuria; Animals; Calcineurin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Deletion; Genes, Reporter; Glomerulosclerosis, Focal Segmental; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Kidney Glomerulus; Kidney Tubules; Mice; Mice, Mutant Strains; Mice, Transgenic; NFATC Transcription Factors; Podocytes; Point Mutation; Puromycin Aminonucleoside; Recombinant Fusion Proteins; Signal Transduction; Tacrolimus; TRPC Cation Channels; TRPC6 Cation Channel	2015

Article

Year

Gq signaling causes glomerular injury by activating TRPC6.

The Journal of clinical investigation, 2015, Volume: 125, Issue:5

Topics: Albuminuria; Animals; Calcineurin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Deletion; Genes, Reporter; Glomerulosclerosis, Focal Segmental; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Kidney Glomerulus; Kidney Tubules; Mice; Mice, Mutant Strains; Mice, Transgenic; NFATC Transcription Factors; Podocytes; Point Mutation; Puromycin Aminonucleoside; Recombinant Fusion Proteins; Signal Transduction; Tacrolimus; TRPC Cation Channels; TRPC6 Cation Channel

2015